[Índice] [Introducción] [Gliales] [Mielina] [Neuronales] [No específicos] [Más frecuentes] [Proliferación] [Bibliografía] |
RHODES RH: Diagnostic immunostaining of the nervous system. In: Immunomucroscopy: A diagnostic tool for the surgical pathologist. C. R. Taylor. Philadelphia WB. Saunders Co 1986, 334-364.
BONNIN JM, RUBINSTEIN. Immunohistochemystry of the central nervous system tumors. Its contribution s to neurosurgical diagnosis.J Neurosurg 1984, 60:121-133.
NAKAJIMA T, KANEYA T, WATANABE S, HIROTA T, SHIMOSATO Y, ISOBE T: S-100 protein distributión in normal and neoplastic tissues. In :De Lellis RA (de) Advances in immunohistochemistry. Masson , New York, 1984, pgs 141-158 .
RUBINSTEIN LJ: Immunohistochemical signposts-notmarkers- in neural tumor differentiation. Neuropathol Appl Neurobiol 1986, 12: 523-537.
TAKAHASHI K, ISOBE T, OHTSUKI Y, AKAGI T, SONOBE H, OKUYAMA T: Immunohistochemical study of the distribution of a e b subunits of S-100 protein in human neoplasms and normal tissues. Virchows Arch Cell Pathol 1984, 45 :385-396.
STEFANSON K, WOLMANN R, JERKOVIC M : S-100 protein in soft tissue tumors derived from schwann cells and melanocytes. Am J Pathol 1982 106: 261-268.
SHARMA S, ABBOTT IR, ZAGZAG D. Malignant intracerebral nerve sheath tumor: a case report and review of the literature. Cancer, 1998 Feb, 82:3, 545-52 .
PERENTES E, RUBINSTEIN LJ: Recents aplications of immunoperoxidase histochemistry in human neurooncology. An update. Arch Pathol Lab Med 1987;111:796-812
BUDKA H. Non glial specificities of immunohistochemistry for the glial fibrilar acidic protein (GFAP). Acta Neuropathol (Berl) 1982, 56: 139-146.
OKURA M, HIRANUMA T, TOMINAGA G, YOSHIOKA H, AIKAWA ,HIRASUNA K, MATSUYA T. Expression of S-100 protein and glial fibrillary acidic protein in cultured submandibular gland epithelial cells and salivary gland tissues. Histogenetic implication for salivary gland tumors. Am J Pathol, 1996 May, 148:5, 1709-16 .
VELASCO ME, ROESSMANN U, GAMETTI PG. Immunohistochemical localization of glial fibrillary acidic protein in human glial neoplasms. Cancer 1980; 45: 484-494.
BURGER P, RAWLINGS CE, COX EB, McLENDON RE, SCHOLD SC, BULLARD DE : Clinicopathological correlation in the oligodendroglioma. Cancer 1987, 59: 1345-1352.
LIEBOBITZ S, HUGHES RAC. Immunology of the nervous system. In Currents topics in immunology. J TURK EDIT. Edward Arnold. London 1983, Vol 17:14.
SCHIFFER D. Brain tumors. Biology , pathology and clinical references. Springer Verlag. Berlin 1997, pgs 62-63.
ARMSTRONG RC, MIGNEAULT A, SHEGOG ML, KIM JG, HUDSON LD; HESSLER RB .High-grade human brain tumors exhibit increased expression of myelin transcription factor 1 (MYT1), a zinc finger DNA-binding protein. J Neuropathol Exp Neurol, 1997 Jul, 56:7, 772-81
BURGER PC, GRAHAM FC, BLIESTE A, KLEHIUES P. Differentiation in neuroblastoma: A histological and immunohistochemical study. Acta Neuropath (Berl) 1987; 73: 115-123.
MUKAI M, TORIKATA C, IRI H, MORIKAWA Y, SHIMIZU K, SHIMODA T, NUKINA N, IHARA Y KAPEYAMA K . Expression fneurofilaments triplet proteins in human neural tumors. Am J Pathol 1985; 122: 139-146.
SCHEMELD, MARANGOS PJ, BRIGHTMAN M. Neuron especific enolase is a molecular marker for peripheral and central neuroendocrine cells. Nature 1978; 276: 834-836.
SESHI L, TRUE L, CARTER D, ROSAI J: Immunohistochemical characterization of a set of monoclonal antibodies to human neuron-specific enolase. Am J Pathol 1988; 131: 258-269.
ZHANG PJ; ROSEMBLUM MK. Synaptophysin expression in the human spinal cord. Diagnostic implications of an immunohistochemical study. Am J Surg Pathol, 1996 Mar, 20:3, 273-6 .
SCHWEICHHEIMER K, WIEDENMANN B, FRANKE WW. Synapthophysin: a reliable marker for medulloblastomas. Virchows Arch (A) Path Anat His 1987; 411:53-59.
BLACK MM; SLAUGHTER T, MOSHIACH S, OBROCKA M, FISCHER. I Tau is enriched on dynamic microtubules in the distal region of growing axons. J Neurosci, 1996 Jun, 16:11, 3601-19
UBERTI D, RIZZINI C, SPANO PF, MEMO M . Immunochemical demostration of Tau protein in undifferentiated cells in medulloblastomas. Neurosci Lett, 1997 Oct, 235:3, 149-53.
DeLACOURTE A, BUEÉ L. Normal and pathological Tau proteins as factors for microtubule assembly. Int Rev Cytol, 1997, 171:, 167-224
AZUMI N, BATTIFORA H. The distribution of Vimentin and Keratin in epithelial and non epithelial neoplasmas. A comprehensive immunohistochemical study in formalin and alcohol fixed tumors. Am J Clin Pathol, 1987, 88: 286-296
HERPERS MJHM, RAMAEKERS FCS, ALDEWEIRELDT J, MOESKER O, SLOOF J. Coexpresion of glial fibrillary acidic protein and vimentin-type intermediate filaments in human astrocitomas. Acta Neuropathol (Berl), 1986; 70:333-339.
PERENTES E, RUBINSTEIN LJ. Immunohistochemical recognition of human neuroepithelial tumors by anti-Leu-7 (HNK-1) monoclonal antibody. Acta Neuropathol 1986; 70:227-233.
BONNIN JM, PERENTES E. Retinal-S antigen immunoreactivity in medulloblastomas. Acta Neuropathol (Berl), 1988; 76:204-207.
MOLENAAR W, JANSSON D, GOULD VE, RORKE LB, FRANKE WW, LEE VM-Y,PACKER RJ, TROJANOVSKY JQ. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors. Monoclonal antibodies to neuronal and glial antigens distinguish subsets of primitive neuroectodermal tumors. Lab Invest 1989; 61: 635-643.
WOLF KH, BUSLEI R, BLÜMCKE I, WIESTLER OD, PIETSCH. Neural antigens in oligodendrogliomas and dysembrioplastic neuroepithelial tumors. Acta Neuropathol (Berl), 1997; 94: 436-443.
BRESALIER RS, YAN P-S, BYRD JC, LOTAN R, RAZ A. Expression of the endogenous galactose-binding protein Galectin-3 correlates with the malignant potential of tumors in the Central Nervous system. Cancer 1997; 80:776-787.
ARIZA A, LÓPEZ D, MATE JL, ISAMAT M, MUSULÉN E, PUJOL E, LEVYA, NAVAS PALACIOS JJ. Role of Cd44 in the invasiveness of glioblastoma multiforme and the noninvasiveness of meningioma: An immunohistochemistry study. Hum Pathol 1995; 26:1144-1147.
HAMPELl H; KÖRSCHENHAUSEN DA; SCHWARZ MJ; FRENZEL KH; JOHNSON JP; PENNING R; ACKENHEIL M; MÜLLER N. Detection of the novel cell adhesion molecule MUC18 in human brain tissue. Neuroimmunomodulation, 1997 Mar, 4:2, 57-61.
NAGASHIMA T, DE ARNOLD SJ, MUROVIC J, HOSHINO T.mmunocytochemical demostration of S-phase cells by anti-bromodeoxyuridine monoclonal antibody in human brain tumor tissues.Acta Neuropathol (Berl) 1985, 67: 155-159.
HOSHINO T, NAGASHIMA T, MUROVIC J: In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling. J Neurosurg 1986, 64: 453-459.
GIANGASPER F, DOGLIONI C, RIVANO MT, PILERI S, GERDES J, STEIN H: Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67. Acta Neuropathol (Berl) 1987, 74: 179-182.
NISHIZAKI T, ORITA T, FURUTANI Y, IKEYAMA Y, AOKI H, SASAKI K: Flow-cytometric DNA analysis and immunohistochemical measurement of Ki-67 and BUdr labeling indices in human brain tumors. J Neurosurg 1989, 70: 379-384.
BURGER PC, SHIBATA T, KLEIHUES P: The use of monoclonal antibody Ki-67 in the identification of proliferating cells: Application to surgical neuropathology. Am J Surg Pathol 1986, 10: 611-617.
ZUBER P, HAMOU, DE TRIBOLET N: Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67. Neurosurgery 1988, 22 (2): 364-368.
HOLLSTEIN M, SIDRANSKY D, VOGELSTEIN B: p53 mutations in human cancers. Science 1991; 253: 49-53
KARAMITOPOULOU E, PERENTES F, DIAMANTIS I, MARAZIOTIS T. Ki-67 immunoreactivity in human central system tumors; a study with MIB 1 monoclonal antibody on archival material. Acta Neuropathol (Berl). 1994; 87: 47-54.
PATT S, GRIES H, GIRALDOM, CERVOS-NAVARRO J, MARTIN H, JÄNISCH W, BROCKMÖLLER J. P53 gene mutations in human astrocytic brain tumors including pilocytic astrocytomas. Hum Pathol 1996 27:586-589.
KRISHNA M., SMITH TW, RECHT LD. Expresion of bcl-2 in reactive and neoplastic astrocytes: lack of correlation with presence or degree of malignancy. J Neurosurg 1995; 83: 1017-1022.
SCHIFFER D, CAVALLA P, MIGHELI A, GIORDANA MT, CHIADO-PIAT L. Bcl-2 distribution in neuroepithelial tumors: an immunohistochemical study. J Neurooncology 1996; 27: 101-109.
NEWCOMB E, BHALLA SK, PARRISH CL, HAYES RL, COHEN H, MILLER DC. Bcl-2 protein expresion in astrocytomas in relation to patient survival and p53 gene status. Acta Neuropathol 1997; 94: 369-375.
GORCZCA W, SARODE V, JUAN G, MELAMED MR; DARZYNKIEWICZ Z. Laser scanning cytometric analysis of cyclin B1 in primary human malignancies. Mod Pathol, 1997 May, 10:5, 457-62 .
CHAKRABARTY A; BRIDGES LR; GRAY S . Cyclin D1 in astrocytic tumours: an immunohistochemical study. Neuropathol Appl Neurobiol, 1996 Aug, 22:4, 311-6
[Índice] [Introducción] [Gliales] [Mielina] [Neuronales] [No específicos] [Más frecuentes] [Proliferación] [Bibliografía] |
